Zimmer Biomet Holdings (ZBH) Tops Q1 EPS by 2c; Narrows Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/28/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Zimmer Biomet (ZBH) PT Raised to $153 at Needham & Company; Buy on Weakness
April 27, 2017 1:46 PM EDTNeedham & Company raised its price target on Zimmer Biomet (NYSE: ZBH) to $153.00 (from $151.00) while maintaining a Strong Buy rating but said disappointing Q1 results return the stock to a "show-me story" but they are recommending investors buy on today's weakness.
Analyst Mike... More
